Sale!

Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4 CD8 Immune Deficiency Panel 2 Markers Test

Original price was: 1,820 د.إ.Current price is: 1,340 د.إ.

-26%

The “Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4 CD8 Immune Deficiency Panel 2 Markers Test” is a comprehensive diagnostic examination offered by DNA Labs UAE, priced at 1340 AED. This test is designed to provide a detailed assessment of an individual’s immune system status, particularly in the context of HIV infection.

The test combines the use of Real-Time Polymerase Chain Reaction (PCR) technology for the quantitative measurement of HIV-1 RNA levels in the blood, which is a direct indicator of the viral load. This is crucial for both the initial diagnosis of HIV infection and the monitoring of patients undergoing antiretroviral therapy.

Additionally, the test includes an immune deficiency panel that evaluates the levels of CD3, CD4, and CD8 cells. These markers are essential components of the immune system, with CD4 cells being a specific target of HIV. The depletion of CD4 cells is a hallmark of HIV progression, making their quantification vital for assessing disease stage and guiding treatment decisions.

By combining viral load testing with immune marker analysis, the test provides a comprehensive overview of an individual’s virological and immunological status. This information is critical for optimizing the management of HIV-infected patients, tailoring antiretroviral therapy, and monitoring response to treatment.

Conducted at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in molecular diagnostics, this test represents a significant tool in the fight against HIV/AIDS, offering patients and healthcare providers alike valuable insights into the disease process and therapeutic efficacy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Human Immuno Virus 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 CD4 CD8 IMMUNE DEFICIENCY PANEL 2 MARKERS Test

Test Name: Human Immuno Virus 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 CD4 CD8 IMMUNE DEFICIENCY PANEL 2 MARKERS Test

Components: Price: 1340.0 AED

Sample Condition: PCR: 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes. Separate plasma aseptically within 2 hours of collection. Ship refrigerated or frozen. 12 hours fasting is recommended. FLOW: 4 mL (3 mL min.) whole blood from 1 Lavender Top (EDTA) tube AND 1 Green top (Sodium Heparin) tube each. Ship at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on Test Request form.

Report Delivery: Sample – Wed / Sat by 11 am; Report – Fri / Tue

Method: Real Time RT-PCR, Flow Cytometry

Test Type: AIDS

Doctor: Physician

Test Department:

Pre Test Information: 12 hours fasting is recommended.

Test Details

The Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test is a diagnostic test used to measure the amount of HIV-1 RNA in the blood. It also includes the analysis of CD3, CD4, and CD8 markers, which are important for assessing the immune system’s response to HIV infection.

The test is performed using a technique called real-time polymerase chain reaction (PCR), which allows for the detection and quantification of HIV-1 RNA. The CD3, CD4, and CD8 markers are analyzed to determine the levels of T lymphocytes in the blood. T lymphocytes play a crucial role in the immune response to HIV infection, and their levels can provide valuable information about the progression of the disease.

This test is typically used for monitoring the effectiveness of antiretroviral therapy (ART) in HIV-infected individuals. By measuring the amount of HIV-1 RNA in the blood and assessing the levels of CD3, CD4, and CD8 markers, healthcare providers can evaluate the response to treatment and make adjustments if necessary.

It is important to note that this test is specifically designed for HIV-1 and does not detect other strains or subtypes of HIV. Additionally, it is not a screening test for HIV infection, but rather a tool for monitoring disease progression and treatment response in individuals already diagnosed with HIV.

Overall, the Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test provides valuable information about the viral load and immune status of HIV-infected individuals, aiding in the management of the disease.

Test Name Human Immuno Virus 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 CD4 CD8 IMMUNE DEFICIENCY PANEL 2 MARKERS Test
Components
Price 1340.0 AED
Sample Condition PCR: 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes. Separate plasma aseptically within 2 hours of collection. Ship refrigerated or frozen. 12 hours fasting is recommended.\n FLOW: 4 mL (3 mL min.) whole blood from 1 Lavender Top (EDTA) tube AND 1 Green top (Sodium Heparin) tube each. Ship at 18-22?\u00f8C. DO NOT REFRIGERATE OR FREEZE. Specify time, date and clinical details on Test Request form.
Report Delivery SampleWed / Sat by 11 am; ReportFri / Tue
Method Real Time RT-PCR, Flow Cytometry
Test type AIDS
Doctor Physician
Test Department:
Pre Test Information 12 hours fasting is recommended.
Test Details

The Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test is a diagnostic test used to measure the amount of HIV-1 RNA in the blood. It also includes the analysis of CD3, CD4, and CD8 markers, which are important for assessing the immune system’s response to HIV infection.

The test is performed using a technique called real-time polymerase chain reaction (PCR), which allows for the detection and quantification of HIV-1 RNA. The CD3, CD4, and CD8 markers are analyzed to determine the levels of T lymphocytes in the blood. T lymphocytes play a crucial role in the immune response to HIV infection, and their levels can provide valuable information about the progression of the disease.

This test is typically used for monitoring the effectiveness of antiretroviral therapy (ART) in HIV-infected individuals. By measuring the amount of HIV-1 RNA in the blood and assessing the levels of CD3, CD4, and CD8 markers, healthcare providers can evaluate the response to treatment and make adjustments if necessary.

It is important to note that this test is specifically designed for HIV-1 and does not detect other strains or subtypes of HIV. Additionally, it is not a screening test for HIV infection, but rather a tool for monitoring disease progression and treatment response in individuals already diagnosed with HIV.

Overall, the Human Immunodeficiency Virus 1 RNA Quantitative Real-Time PCR with CD3 CD4/CD8 (Immune Deficiency Panel 2) Markers Test provides valuable information about the viral load and immune status of HIV-infected individuals, aiding in the management of the disease.